{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:08:20Z","timestamp":1782252500098,"version":"3.54.5"},"reference-count":110,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Genetics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.tig.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T20:01:54Z","timestamp":1370376114000},"page":"488-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mitochondrial disorders: aetiologies, models systems, and candidate therapies"],"prefix":"10.1016","volume":"29","author":[{"given":"G. Jane","family":"Farrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Chadderton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Kenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Millington-Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tig.2013.05.005_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/426127a","article-title":"Evolutionary biology: essence of mitochondria","volume":"426","author":"Henze","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2012.08.013","article-title":"Mitochondrial diseases: translation matters","volume":"55","author":"Pearce","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tig.2013.05.005_bib0015","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","article-title":"Detection of ultra-rare mutations by next-generation sequencing","volume":"109","author":"Schmitt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/hmg\/dds435","article-title":"Universal heteroplasmy of human mitochondrial DNA","volume":"22","author":"Payne","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0025","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/ijms14022388","article-title":"Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress","volume":"14","author":"Ciccone","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tig.2013.05.005_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2012.03.010","article-title":"Mitochondrial pharmacology","volume":"33","author":"Smith","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tig.2013.05.005_bib0035","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1167\/iovs.10-5429","article-title":"Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration","volume":"51","author":"Karunadharma","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tig.2013.05.005_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tig.2013.05.005_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mcn.2012.08.004","article-title":"The optic nerve: a \u201cmito\u2013window\u201d on mitochondrial neurodegeneration","volume":"55","author":"Maresca","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tig.2013.05.005_bib0050","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/eye.2011.2","article-title":"Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations","volume":"25","author":"Yu-Wai-Man","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.tig.2013.05.005_bib0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrneurol.2012.167","article-title":"Treatment of hereditary optic neuropathies","volume":"8","author":"Newman","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tig.2013.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/02713683.2011.607536","article-title":"Mitochondrial dysfunction in retinal diseases","volume":"36","author":"Barot","year":"2011","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.tig.2013.05.005_bib0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.gene.2012.12.066","article-title":"A novel mitochondrial mutation m.8989G>C associated with neuropathy, ataxia, retinitis pigmentosa: the NARP syndrome","volume":"515","author":"Duno","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.tig.2013.05.005_bib0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/nar\/gks965","article-title":"Mitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre Syndrome","volume":"41","author":"Comte","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2013.05.005_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/emboj.2012.300","article-title":"OXPHOS mutations and neurodegeneration","volume":"32","author":"Koopman","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.tig.2013.05.005_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcb.2012.10.006","article-title":"Mitochondrial dynamics in neurodegeneration","volume":"23","author":"Itoh","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tig.2013.05.005_bib0085","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1093\/nar\/gks770","article-title":"Mitochondrial DNA copy number is regulated in a tissue specific manner by DNA methylation of the nuclear-encoded DNA polymerase gamma A","volume":"40","author":"Kelly","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2013.05.005_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/brain\/awr326","article-title":"Sensory neuronopathy in patients harbouring recessive polymerase \u03b3 mutations","volume":"135","author":"Lax","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.tig.2013.05.005_bib0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biocel.2013.01.005","article-title":"Mitochondria: mitochondrial RNA metabolism and human disease","volume":"45","author":"Nicholls","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tig.2013.05.005_bib0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/302344","article-title":"Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene","volume":"64","author":"Mansergh","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ng.2007.63","article-title":"A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes","volume":"40","author":"Cree","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bjo.83.5.577","article-title":"Smoking as an aetiological factor in a pedigree with Leber hereditary optic neuropathy","volume":"83","author":"Tsao","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.tig.2013.05.005_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1289\/ehp.9245","article-title":"Grand rounds: could occupational exposure to n-hexane and other solvents precipitate visual failure in Leber hereditary optic neuropathy?","volume":"115","author":"Carelli","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tig.2013.05.005_bib0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.eye.6700362","article-title":"Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus","volume":"17","author":"Mackey","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.tig.2013.05.005_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13816810701867607","article-title":"Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy","volume":"29","author":"Shankar","year":"2008","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0135","doi-asserted-by":"crossref","first-page":"e1002488","DOI":"10.1371\/journal.pgen.1002488","article-title":"The mitochondrial chaperone protein TRAP1 mitigates \u03b1-Synuclein toxicity","volume":"8","author":"Butler","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mito.2008.10.002","article-title":"Human mitochondrial variants influence on oxygen consumption","volume":"9","author":"Marcuello","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tig.2013.05.005_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/519394","article-title":"Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background","volume":"81","author":"Hudson","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0150","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbadis.2012.04.014","article-title":"Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy","volume":"1822","author":"G\u00f3mez-Dur\u00e1n","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tig.2013.05.005_bib0155","doi-asserted-by":"crossref","first-page":"e45134","DOI":"10.1371\/journal.pone.0045134","article-title":"Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A\/H6A1B: The Cache County Study on Memory in Aging","volume":"7","author":"Ridge","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0160","doi-asserted-by":"crossref","first-page":"e30874","DOI":"10.1371\/journal.pone.0030874","article-title":"Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study","volume":"7","author":"Mueller","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0165","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/hmg\/ddq246","article-title":"Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups","volume":"19","author":"G\u00f3mez-Dur\u00e1n","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0170","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI64125","article-title":"The role of mitochondria in aging","volume":"123","author":"Bratic","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tig.2013.05.005_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0180","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1073\/pnas.0508886102","article-title":"Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production","volume":"102","author":"Trifunovic","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0185","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.tig.2013.05.005_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington's disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tig.2013.05.005_bib0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nmd.2011.07.009","article-title":"Partial tandem duplication of mtDNA-tRNA(Phe) impairs mtDNA translation in late-onset mitochondrial myopathy","volume":"22","author":"Arzuffi","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.tig.2013.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbadis.2012.01.010","article-title":"Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS","volume":"1822","author":"Desquiret-Dumas","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tig.2013.05.005_bib0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/brain\/awq015","article-title":"Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations","volume":"133","author":"Abramov","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.tig.2013.05.005_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/gt.2011.134","article-title":"Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors","volume":"19","author":"Iyer","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0215","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1093\/hmg\/ddq370","article-title":"Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis","volume":"19","author":"Burbulla","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0220","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/hum.2011.177","article-title":"Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells","volume":"23","author":"Iyer","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0225","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","article-title":"Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 iPS cells","volume":"31","author":"Seibler","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tig.2013.05.005_bib0230","doi-asserted-by":"crossref","first-page":"141ra90","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tig.2013.05.005_bib0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/embor.2008.242","article-title":"Mouse models of mitochondrial DNA defects and their relevance for human disease","volume":"10","author":"Tyynismaa","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tig.2013.05.005_bib0240","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1006214107","article-title":"Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbagen.2011.08.005","article-title":"Animal models of human mitochondrial DNA mutations","volume":"1820","author":"Dunn","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tig.2013.05.005_bib0250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tig.2013.05.005_bib0255","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/hmg\/ddt051","article-title":"TWINKLE is an essential mitochondrial helicase required for synthesis of nascent D-loop strands and complete mtDNA replication","volume":"22","author":"Milenkovic","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/541245","article-title":"Nuclear expression of a mitochondrial DNA gene: mitochondrial targeting of allotopically expressed mutant ATP6 in transgenic mice","author":"Dunn","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.tig.2013.05.005_bib0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.06-0789","article-title":"The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse","volume":"48","author":"Qi","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tig.2013.05.005_bib0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mito.2010.07.003","article-title":"Xenomitochondrial mice: investigation into mitochondrial compensatory mechanisms","volume":"11","author":"Cannon","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tig.2013.05.005_bib0280","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1538\/expanim.60.421","article-title":"Transmitochondrial mice as models for mitochondrial DNA-based diseases","volume":"60","author":"Nakada","year":"2011","journal-title":"Exp. Anim."},{"key":"10.1016\/j.tig.2013.05.005_bib0285","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0290","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/em.20570","article-title":"The approaches for manipulating mitochondrial proteome","volume":"51","author":"Shokolenko","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.tig.2013.05.005_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2012.05.014","article-title":"Targeting drugs to mitochondria","volume":"82","author":"Heller","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tig.2013.05.005_bib0300","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.mad.2011.05.002","article-title":"Mitochondrial transfection for studying organellar DNA repair, genome maintenance and aging","volume":"132","author":"Mileshina","year":"2011","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.tig.2013.05.005_bib0305","article-title":"Targeting nucleic acids into mitochondria: progress and prospects","author":"Niazi","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tig.2013.05.005_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2010.05.070","article-title":"Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes","volume":"397","author":"Yasuzaki","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tig.2013.05.005_bib0315","article-title":"Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier","author":"Yamada","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tig.2013.05.005_bib0320","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1007\/s11095-011-0544-0","article-title":"Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome","volume":"28","author":"Lyrawati","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tig.2013.05.005_bib0325","first-page":"106","article-title":"Mitochondria-targeted antioxidants as therapies","volume":"11","author":"Smith","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.tig.2013.05.005_bib0330","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tig.2013.05.005_bib0335","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s11095-011-0476-8","article-title":"Novel therapies targeting inner mitochondrial membrane: from discovery to clinical development","volume":"28","author":"Szeto","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tig.2013.05.005_bib0340","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/hum.2009.023","article-title":"Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model","volume":"20","author":"Keeney","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.mito.2011.10.001","article-title":"Modulation of mitochondrial respiratory capacity by carrier-mediated transfer of RNA in vivo","volume":"12","author":"Jash","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tig.2013.05.005_bib0350","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mt.2012.250","article-title":"Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0355","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2011.06.051","article-title":"The human mitochondrial transcriptome","volume":"146","author":"Mercer","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tig.2013.05.005_bib0360","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1073\/pnas.1116792109","article-title":"Correcting human mitochondrial mutations with targeted RNA import","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0365","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF03402122","article-title":"Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency","volume":"5","author":"Zimmer","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.tig.2013.05.005_bib0370","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2011.111","article-title":"Sustained correction of OTC deficiency in spf(ash) mice using optimized self-complementary AAV2\/8 vectors","volume":"19","author":"Wang","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0375","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/emmm.201201433","article-title":"Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy","volume":"4","author":"Di","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tig.2013.05.005_bib0380","doi-asserted-by":"crossref","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0385","doi-asserted-by":"crossref","first-page":"e11472","DOI":"10.1371\/journal.pone.0011472","article-title":"Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model","volume":"5","author":"Marella","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0390","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ejhg.2012.112","article-title":"Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy","volume":"21","author":"Chadderton","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0395","article-title":"Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease","author":"Bacman","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14656566.2012.657177","article-title":"Drugs and mitochondrial diseases: 40 queries and answers","volume":"13","author":"Mancuso","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.tig.2013.05.005_bib0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tig.2013.05.005_bib0410","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.tig.2013.05.005_bib0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature11647","article-title":"Towards germline gene therapy of inherited mitochondrial diseases","volume":"493","author":"Tachibana","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0420","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature11800","article-title":"Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants","volume":"493","author":"Paull","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0425","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature08368","article-title":"Mitochondrial gene replacement in primate offspring and embryonic stem cells","volume":"461","author":"Tachibana","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature08958","article-title":"Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease","volume":"465","author":"Craven","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0435","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.tig.2013.05.005_bib0440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(02)00327-0","article-title":"Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction","volume":"326","author":"Zhang","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tig.2013.05.005_bib0445","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson's disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.tig.2013.05.005_bib0450","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cmet.2008.02.004","article-title":"Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy","volume":"7","author":"Kruse","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tig.2013.05.005_bib0455","doi-asserted-by":"crossref","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0460","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature01034","article-title":"The harlequin mouse mutation downregulates apoptosis-inducing factor","volume":"419","author":"Klein","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tig.2013.05.005_bib0465","doi-asserted-by":"crossref","first-page":"e3208","DOI":"10.1371\/journal.pone.0003208","article-title":"The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes","volume":"3","author":"B\u00e9nit","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0470","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nsmb805","article-title":"Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia","volume":"11","author":"Graziewicz","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2013.05.005_bib0475","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mcn.2012.07.004","article-title":"Mouse models of age-related mitochondrial neurosensory hearing loss","volume":"55","author":"Han","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tig.2013.05.005_bib0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/90058","article-title":"Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria","volume":"28","author":"Spelbrink","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0485","doi-asserted-by":"crossref","first-page":"17687","DOI":"10.1073\/pnas.0505551102","article-title":"Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice","volume":"102","author":"Tyynismaa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2013.05.005_bib0490","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng0797-226","article-title":"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator","volume":"16","author":"Graham","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0495","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.1147786","article-title":"A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations","volume":"319","author":"Fan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tig.2013.05.005_bib0500","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/82826","article-title":"Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes","volume":"26","author":"Inoue","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2013.05.005_bib0505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2004.08.073","article-title":"Accumulation of pathogenic DeltamtDNA induced deafness but not diabetic phenotypes in mito-mice","volume":"323","author":"Nakada","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tig.2013.05.005_bib0510","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1016\/j.febslet.2010.07.048","article-title":"Generation of trans-mitochondrial mito-mice by the introduction of a pathogenic G13997A mtDNA from highly metastatic lung carcinoma cells","volume":"584","author":"Yokota","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tig.2013.05.005_bib0515","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tig.2013.05.005_bib0520","doi-asserted-by":"crossref","first-page":"2ra4","DOI":"10.1126\/scitranslmed.3000130","article-title":"Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia","volume":"1","author":"Jarraya","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tig.2013.05.005_bib0525","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1172\/JCI62923","article-title":"Fatal breathing dysfunction in a mouse model of Leigh syndrome","volume":"122","author":"Quintana","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tig.2013.05.005_bib0530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/brain\/awr290","article-title":"Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy","volume":"135","author":"Bouaita","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.tig.2013.05.005_bib0535","first-page":"438370","article-title":"Protective role of rAAV-NDI1, serotype 5, in an acute MPTP mouse Parkinson's model","volume":"2011","author":"Barber-Singh","year":"2010","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.tig.2013.05.005_bib0540","doi-asserted-by":"crossref","first-page":"14250","DOI":"10.1074\/jbc.M600922200","article-title":"In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease","volume":"281","author":"Seo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tig.2013.05.005_bib0545","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1371\/journal.pone.0001433","article-title":"Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease","volume":"3","author":"Marella","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2013.05.005_bib0550","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.200900006","article-title":"Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function","volume":"1","author":"Morais","year":"2009","journal-title":"EMBO Mol. Med."}],"container-title":["Trends in Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016895251300084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016895251300084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:05:11Z","timestamp":1759190711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016895251300084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S016895251300084X"],"URL":"https:\/\/doi.org\/10.1016\/j.tig.2013.05.005","relation":{},"ISSN":["0168-9525"],"issn-type":[{"value":"0168-9525","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial disorders: aetiologies, models systems, and candidate therapies","name":"articletitle","label":"Article Title"},{"value":"Trends in Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tig.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}